NPS Pharma (NPSP) Target Raised to $45 at Janney
Tweet Send to a Friend
Janney Montgomery Scott maintained a Buy rating on NPS Pharmaceuticals Inc. (NASDAQ: NPSP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE